Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
H(1)R expression by CD11B(+) cells is not required for susceptibility to experimental allergic encephalomyelitis.
Multiple sclerosis: Reprogramming the immune repertoire with alemtuzumab in MS.
Obesity interacts with infectious mononucleosis in risk of multiple sclerosis.
Whom to Target for Falls-Prevention Trials: Recommendations from the International MS Falls Prevention Research Network.
Cognitive rehabilitation in multiple sclerosis: a randomized controlled trial.
Fingolimod induces the transition to a nerve regeneration promoting Schwann cell phenotype.
Direction-specific impairments of limits of stability in individuals with multiple sclerosis.
Neurofibromatosis type 1 and chronic neurological conditions in the United States: an administrative claims analysis.
Why are prions and amyloid structures immune suppressive and other intriguing questions facing neuroimmunologists in the future.
Psoriasis and comorbidities. Epidemiological studies.
Stem and Progenitor Cell-Based Therapy of the Central Nervous System: Hopes, Hype, and Wishful Thinking.
[The treatment by expanded ex vivo autologous regulatory T-cells CD4+CD25+FoxP3+CD127low restores the balance of immune system in patients with remitting-relapsing multiple sclerosis].
A new CSF1R mutation presenting with an extensive white matter lesion mimicking primary progressive multiple sclerosis.
A case of fulminant neuromyelitis optica presenting with destructive lesions in whole-brain.
Guillain Barré syndrome and other immune mediated neuropathies: Diagnosis and classification.
Childhood-onset multiple sclerosis: report of 82 patients from Isfahan, Iran.
Ultraviolet radiation, vitamin D and multiple sclerosis.
Protoporphyrin Treatment Modulates Susceptibility to Experimental Autoimmune Encephalomyelitis in miR-155-Deficient Mice.
Hepatic but Not CNS-Expressed Human C-Reactive Protein Inhibits Experimental Autoimmune Encephalomyelitis in Transgenic Mice.
Eomesodermin-expressing T-helper cells are essential for chronic neuroinflammation.
Cancer specific risk in multiple sclerosis patients.
Why does multiple sclerosis only affect human primates?
Oligodendrocyte progenitor programming and reprogramming: Toward myelin regeneration.
Intranasal brain delivery of cationic nanoemulsion-encapsulated TNFα siRNA in prevention of experimental neuroinflammation.
Clemastine Enhances Myelination in the Prefrontal Cortex and Rescues Behavioral Changes in Socially Isolated Mice.
Pages
« first
‹ previous
…
662
663
664
665
666
667
668
669
670
…
next ›
last »